Top Markets
Coin of the day
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
Kedudukan dalam Saham #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Harga Saham
$0.12164306
Disegerakkan terakhir: 2024-11-11
Modal Pasaran
$38.53M
Perubahan (1 hari)
-4.14%
Perubahan (1 tahun)
0.00%
Negara
AU
Perdagangan PharmAust Limited (PAA)

Kategori

Sejarah harga saham bagi PharmAust Limited (PAA)
Harga penutupan tertinggi: $0.12 pada 2024-11-01

Harga penutupan terendah: $3.11 pada 2001-10-01
Sejarah harga saham PharmAust Limited dari 2001 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2024 72.79%
2023 61.50%
2022 -33.17%
2021 -20.54%
2020 20.68%
2019 171.67%
2018 -30.35%
2017 4.90%
2016 -29.98%
2015 -55.93%
2014 -33.04%
2013 25.44%
2012 -54.31%
2011 -8.75%
2010 -46.71%
2009 152.12%
2008 -65.75%
2007 -55.38%
2006 -27.70%
2005 -34.70%
2004 20.98%
2003 69.43%
2002 -28.84%
2001 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$546.39 38.55%
US
$1.03K 56.51%
NL
$120.74 -14.98%
AU
$142.97 431.68%
US
$763.17 7.23%
CH